Skip to Content

Investor Update

Basel 24 September 2009

Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer

Dear Investor,
Please find enclosed a press release by Chugai:

See attached Chugai press release